Les adénovirus réplicatifs conditionnels: Un second souffle pour la thérapie génique du cancer

Translated title of the contribution: Conditionally replicative adenoviruses: A second wind for cancer gene therapy

Jacques Grill, Birgit Geoerger, Martine Lamfers, Clemens Dirven, Victor Van Beusechem, Winald Gerritsen, Gilles Vassal

Research output: Contribution to journalReview article

Abstract

Cancer gene therapy has offered many hopes but its first use in humans revealed some pitfalls and at least three main problems: lack of efficacy and specificity of current vectors to deliver therapeutic genes, poor diffusion of the therapeutic effects inside the tumor (absence of bystander effect), poor distribution of the vectors injected inside the tissue. To address some of these issues, several teams have developped tumor selective replicating adenoviruses, some of them being already in the clinic. First results are promissing but complementary studies are needed to define if these agents will take place in the therapeutic armentorium against cancer.

Translated title of the contributionConditionally replicative adenoviruses: A second wind for cancer gene therapy
Original languageFrench
Pages (from-to)1039-1048
Number of pages10
JournalBulletin du Cancer
Volume90
Issue number12
StatePublished - Dec 1 2003

Keywords

  • Oncolysis
  • Onyx 015
  • Replication
  • Virus

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'Conditionally replicative adenoviruses: A second wind for cancer gene therapy'. Together they form a unique fingerprint.

  • Cite this

    Grill, J., Geoerger, B., Lamfers, M., Dirven, C., Van Beusechem, V., Gerritsen, W., & Vassal, G. (2003). Les adénovirus réplicatifs conditionnels: Un second souffle pour la thérapie génique du cancer. Bulletin du Cancer, 90(12), 1039-1048.